Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis
Itsuki Terao, Wakako Kodama
Topics & Concepts
TolerabilityPlaceboMedicineMeta-analysisRandomized controlled trialAlzheimer's diseaseLithium (medication)DementiaClinical trialClinical Dementia RatingInternal medicineDiseaseAdverse effectPsychiatryPathologyAlternative medicinePhosphodiesterase function and regulationDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments